127
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Screening and Analysis of Potential Critical Gene in Acute Myocardial Infarction Based on a miRNA-mRNA Regulatory Network

ORCID Icon, , , , &
Pages 2847-2860 | Published online: 10 Mar 2022

References

  • Castro-Dominguez Y, Dharmarajan K, McNamara RL. Predicting death after acute myocardial infarction. Trends Cardiovasc Med. 2018;28(2):102–109. doi:10.1016/j.tcm.2017.07.011
  • Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053–2064. doi:10.1056/NEJMra1606915
  • Roffi M, Patrono C, Collet JP, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267–315. doi:10.1093/eurheartj/ehv32
  • Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361(9):868–877. doi:10.1056/NEJMoa0903515
  • Abbas NA, John RI, Webb MC, et al. Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem. 2005;51(11):2059–2066. doi:10.1373/clinchem.2005.055665
  • Røsjø H, Varpula M, Hagve TA, et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 2011;37(1):77–85. doi:10.1007/s00134-010-2051-x
  • Liebetrau C, Möllmann H, Dörr O, et al. Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol. 2013;62(11):992–998. doi:10.1016/j.jacc.2013.05.025
  • Dawson K, Wakili R, Ordög B, et al. MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation. Circulation. 2013;127(14):1466–1475. doi:10.1161/circulationaha.112.001207
  • Longgang H, An Y. Expressions and clinical significance of plasma microRNA-1 and urothelial carcinoma associated 1 gene in patients with acute myocardial infarction. Chin. J Evid Based Cardiovasc Med. 2017;12:1468–1470.
  • Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007;101(12):1225–1236. doi:10.1161/circresaha.107.163147
  • Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 2013;41:D991–D995. doi:10.1093/nar/gks1193
  • Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854. doi:10.1016/0092-8674(93)90529-y
  • Yu L, Yao T, Jiang Z, et al. Integrated analysis of miRNA-mRNA regulatory networks associated with osteonecrosis of the femoral head. Evid Based Complement Alternat Med. 2021;2021:8076598. doi:10.1155/2021/8076598
  • Suh J, Kim D-H, Lee Y-H, et al. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling. Mol Carcinog. 2020;59(9):1028–1040. doi:10.1002/mc.23233
  • Liu H, Sun J. Relationship between serum levels of visfatin, matrix metalloproteinase in acute myocardial infarction patients. Chin J Geriatr Heart Brain Vessel Dis. 2018;21:389–391.
  • Nigro N, Winzeler B, Suter-Widmer I, et al. Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia. J Intern Med. 2015;278(1):29–37. doi:10.1111/joim.12332
  • Stupack DG, Cheresh DA. Integrins and angiogenesis. Curr Top Dev Biol. 2004;207–238. doi:10.1016/s0070-2153(04)64009-9
  • Bafetti LM, Young TN, Itoh Y, et al. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J Biol Chem. 1998;273(1):143–149. doi:10.1074/jbc.273.1.143
  • Hodivala-Dilke KM, Reynolds AR, Reynolds LE. Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res. 2003;314(1):131–144. doi:10.1007/s00441-003-0774-5
  • Szekanecz Z, Besenyei T, Szentpétery A, et al. Angiogenesis and vasculogenesis in rheumatoid arthritis. Curr Opin Rheumatol. 2010;22(3):299–306. doi:10.1097/BOR.0b013e328337c95a
  • Yang YH, Wang Y, Lam KS, et al. Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4. Arterioscler Thromb Vasc Biol. 2008;28(5):835–840. doi:10.1161/atvbaha.107.157776
  • Karar J, Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front Mol Neurosci. 2011;4:51. doi:10.3389/fnmol.2011.00051
  • Audero E, Cascone I, Maniero F, et al. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells. J Biol Chem. 2004;279(13):13224–13233. doi:10.1074/jbc.M307456200